查找临床试验
已按「膀胱癌」检索，对应国际通用词 bladder cancer
共找到 105 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:25，每 5 分钟自动同步Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC)
China
年龄 18 Years – 75 Years
Tongji Hospital
Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer
China
年龄 18 Years – 不限
Changhai Hospital
A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing
China
年龄 18 Years – 80 Years
The First Affiliated Hospital with Nanjing Medical University
Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer
China
年龄 18 Years – 75 Years
Fujian Medical University Union Hospital
Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder
China
年龄 18 Years – 100 Years
Zhujiang Hospital
A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC
China
年龄 18 Years – 不限
Shanghai Hengrui Pharmaceutical Co., Ltd.
Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer
China
年龄 18 Years – 不限
Tianjin Medical University Second Hospital
Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
China
年龄 18 Years – 不限
Zhuhai Beihai Biotech Co., Ltd
Development of an AI-Agent for Urological Disease Diagnosis and Treatment
China
年龄 不限 – 不限
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
China
年龄 18 Years – 不限
Tianjin Medical University Second Hospital
EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC
China
年龄 18 Years – 80 Years
Peking University Third Hospital
Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer
China
年龄 18 Years – 75 Years
First Affiliated Hospital of Zhejiang University